Recombinant Human Lumican/LUM Protein，His

Lumican, a member of the small leucine-rich proteoglycan family, plays a crucial role in extracellular matrix (ECM) organization and regulation of cell behavior. It is primarily expressed in connective tissues, including cartilage and corneal stroma, where it is involved in collagen fibril formation and maintenance of tissue integrity. Recent studies have highlighted Lumican's significance beyond structural functions; it is implicated in various pathological conditions, including cancer progression and fibrosis. The recombinant expression of Lumican (LUM) protein has garnered attention for its potential therapeutic applications, particularly in regenerative medicine. By producing LUM as a recombinant protein, researchers aim to investigate its specific interactions with cell surface receptors and ECM components, facilitating a deeper understanding of its biological roles. This has led to exploration of its use in improving wound healing, modulating inflammation, and even enhancing the efficacy of cancer treatments. Through advanced biotechnological methods, including gene cloning and protein purification, researchers are working to clarify Lumican’s multifaceted functions and optimize its application in clinical settings. The ongoing research is expected to provide insights into how manipulating Lumican levels could be harnessed for therapeutic strategies in various diseases, ultimately contributing to the development of novel treatments that leverage the regenerative properties of this important proteoglycan.